# Intraperitoneal Tramadol Versus Dexmedetomedine for Analgesia After Abdominal Laparoscopic Cancer Surgeries

> **NCT04813016** · PHASE2,PHASE3 · COMPLETED · sponsor: **National Cancer Institute, Egypt** · enrollment: 100 (actual)

## Conditions studied

- Analgesia

## Interventions

- **DRUG:** Tramal 1
- **DRUG:** Tramal 2
- **DRUG:** Dexmedetomidine 1
- **DRUG:** dexmedetomidine 2

## Key facts

- **NCT ID:** NCT04813016
- **Lead sponsor:** National Cancer Institute, Egypt
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-01
- **Primary completion:** 2022-04-30
- **Final completion:** 2022-05-01
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2022-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04813016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04813016, "Intraperitoneal Tramadol Versus Dexmedetomedine for Analgesia After Abdominal Laparoscopic Cancer Surgeries". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04813016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*